Market by Gender, End-user, and Country | Forecast 2021-2028
According to Triton’s report,
Europe’s infertility testing and treatment market is estimated to garner a CAGR
of 10.25% in revenue during the estimated years of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries researched in this
market include:
• The United Kingdom
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
In Europe, several fertility
clinics have commenced operations, owing to the rising demand for treatments.
The market’s growth is primarily due to the late conception. Along with this,
the growing awareness pertaining to infertility has increased the demand for
infertility testing and treatments. Hence, such developments are likely to
support the infertility testing and treatment market’s growth across the
region.
In the United Kingdom, there
has been a significant rise in infertility rates over the past few years. This
is mainly owing to the rise in the aging population and falling fertility
rates. Furthermore, the National Health Service funds fertility treatments in
various cases, reducing the burden of costs on people. Above all, the country
has shown success in IVF treatments, with success rates tripled over the last
20 years. Therefore, supportive government measures and a growing aging
population increase the need for infertility treatments, thereby supplementing
the progression of the infertility testing and treatment market within the
United Kingdom.
Similarly, the rise in
infertility rates has influenced the need for infertility treatment across
Germany. Factors such as the rising age, development of PCOS, obesity, and
multiple miscarriages are also increasing the demand for treatments like IVF.
Hence, such factors indicate the growth in demand for infertility testing and
treatments, simultaneously propelling the infertility testing and treatment
market on a growth path.
EMD Group (Merck KGAA) is a science and technology company known as Merck in other nations except in the US and Canada, where it functions under the name EMD Group. It operates under three business segments, such as healthcare, life science, and performance materials. The company offers prescription medicines for treating cancer, multiple sclerosis, infertility, and others. Besides, it conducts research, offering scientists with lab materials, technologies, and services. EMD operates across various countries, with headquarters in Germany.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. KEY
INSIGHTS
2.1.1. GROWING
DEMAND FOR LOW-COST PROCEDURES
2.1.2. INCREASING
ACCEPTANCE OF DONOR EGGS
2.1.3. USE OF
AI INCREASES THE SUCCESS OF IVF TREATMENT
2.2. IMPACT
OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. TREATMENT
OPTIONS
2.4.2. QUALITY
OF MEDICAL PROCEDURES
2.4.3. PRICE
OF TREATMENTS
2.4.4. SHIFT
TOWARDS MEDICAL TOURISM
2.4.5. REIMBURSEMENT
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. INDUSTRY
COMPONENTS
2.6.1. RAW MATERIAL
PROCUREMENT
2.6.2. MANUFACTURING
2.6.3. SUPPLY
LOGISTICS
2.6.4. DISTRIBUTION
CHANNELS
2.6.5. END-USERS
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
& PARTNERSHIPS
2.8.2. ACQUISITIONS
& MERGERS
2.8.3. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. GROWTH
IN STRESS AND LIFESTYLE DISORDERS
2.9.2. RISING
TRENDS IN DELAYED MARRIAGES AND PREGNANCIES
2.9.3. IMPROVEMENTS
IN TREATMENTS
2.9.4. GOVERNMENT
SUPPORT
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST
2.10.2. SOCIAL
TABOO PERTAINING TO INFERTILITY
2.10.3. RISKS
ASSOCIATED WITH TREATMENTS
2.11. MARKET
OPPORTUNITIES
2.11.1. TECHNOLOGY
ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY
2.11.2. ADVANCES
IN EMBRYO BIOPSY AND GENETIC SCREENING
3. EUROPE
INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER
3.1. MALE
3.1.1. MALE
INFERTILITY TESTING
3.1.1.1. DNA
FRAGMENTATION
3.1.1.2. OXIDATIVE
STRESS ANALYSIS
3.1.1.3. SPERM
PENETRATION ASSAY
3.1.1.4. COMPUTER-ASSISTED
SEMEN ANALYSIS (CASA)
3.1.1.5. SPERM AGGLUTINATION
3.1.1.6. MICROSCOPIC
EXAMINATION
3.1.1.7. OTHERS
3.1.2. MALE
INFERTILITY TREATMENT
3.1.2.1. MEDICATION
3.1.2.2. ASSISTED
REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
3.2. FEMALE
3.2.1. FEMALE
INFERTILITY TESTING
3.2.1.1. OVULATION
TESTING
3.2.1.2. HYSTEROSALPINGOGRAPHY
3.2.1.3. LAPAROSCOPY
3.2.1.4. TRANSVAGINAL
ULTRASOUND
3.2.1.5. OVARIAN
RESERVE TESTING
3.2.1.6. HORMONAL
LEVEL TESTING
3.2.1.7. OTHERS
3.2.2. FEMALE
INFERTILITY TREATMENT
3.2.2.1. IVF
WITH ICSI
3.2.2.2. IUI
3.2.2.3. IVF
WITHOUT ICSI
3.2.2.4. SURROGACY
3.2.2.5. THERS
4. EUROPE
INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER
4.1. FERTILITY
AND SURGICAL CENTERS
4.2. HOSPITALS
& RESEARCH LABORATORIES
4.3. CRYOBANKS
5. EUROPE
INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK
5.1. UNITED
KINGDOM
5.2. GERMANY
5.3. FRANCE
5.4. SPAIN
5.5. ITALY
5.6. RUSSIA
5.7. REST
OF EUROPE
6. COMPETITIVE
LANDSCAPE
6.1. ADORFEM
6.2. BANGKOK
IVF CENTER
6.3. COOK
MEDICAL INC
6.4. COOPER
SURGICAL
6.5. CREATE
FERTILITY CENTRE
6.6. EMD
GROUP (MERCK KGAA)
6.7. ENDO
INTERNATIONAL PLC
6.8. FERRING
PHARMACEUTICALS
6.9. HALOTECH
DNA
6.10. GENEA
LTD
6.11. FUJIFILM
IRVINE SCIENTIFIC
6.12. VITROLIFE
AB
6.13. LABOTECT
GMBH
6.14. OLYMPUS
CORPORATION
6.15. PROGYNY
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS
MATRIX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS
& PARTNERSHIPS
TABLE 5: LIST OF ACQUISITIONS
& MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES
TABLE 7: AVERAGE COST
COMPARISON OF INFERTILITY TREATMENTS
TABLE 8: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
TABLE 11: ROS AND CONS OF DNA
SHARING METHODS
TABLE 12: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
TABLE 13: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
TABLE 15: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
TABLE 16: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)
FIGURE 5: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028 (IN %)
FIGURE 7: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
FIGURE 8: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2020 & 2028 (IN
%)
FIGURE 9: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)
FIGURE 10: CAUSES OF SPERM DNA
FRAGMENTATION
FIGURE 11: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $
MILLION)
FIGURE 12: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $
MILLION)
FIGURE 13: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA),
2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $
MILLION)
FIGURE 16: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
FIGURE 18: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2020 & 2028
(IN %)
FIGURE 19: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY &
VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 22: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN %)
FIGURE 23: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $
MILLION)
FIGURE 24: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2020 & 2028
(IN %)
FIGURE 25: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)
FIGURE 26: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $
MILLION)
FIGURE 27: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE 28: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $
MILLION)
FIGURE 29: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $
MILLION)
FIGURE 30: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)
FIGURE 31: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 32: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $
MILLION)
FIGURE 33: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2020 & 2028
FIGURE 34: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)
FIGURE 35: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)
FIGURE 36: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)
FIGURE 37: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)
FIGURE 38: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 39: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE 40: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN
$ MILLION)
FIGURE 41: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH LABORATORIES,
2021-2028 (IN $ MILLION)
FIGURE 42: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)
FIGURE 43: EUROPE INFERTILITY
TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 44: UNITED KINGDOM
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: GERMANY INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: FRANCE INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: SPAIN INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 48: ITALY INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 49: RUSSIA INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 50: REST OF EUROPE
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)